- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01344811
Effects of Telemonitoring Service for Obesity Care (Smart-OB)
A Randomized, Open, Parallel, Multi-center Trial to Evaluate Weight Loss Efficacy of Smart Care Service in Obese Patients With Metabolic Syndrome.
연구 개요
상세 설명
- Objectives : To evaluate superiority of U(Ubiquitous)-Healthcare(hereinafter referred to as Smart Care) Service being combined conventional treatment with health care service, in comparison to conventional treatment in obese patients with metabolic syndrome.
Test and control group
- Test groups : The subject group who is receiving health care services using conventional treatment (hospital visit) and Smart Care Service (Telemonitoring).
- Control group : The subject group who is receiving conventional treatment (hospital visit).
- Target Subject: Obese patients with metabolic syndrome.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Seoul, 대한민국
- Seoul National University Hospital
-
Seoul, 대한민국
- Yonsei University Health System
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Age: More than 20 years of age and under 70 years of age.
- BMI ≥ 25kg/m2
Patients with metabolic syndrome (who have more than three of following 5 components of metabolic syndrome) and who are able to receive outpatient treatment.
A. Abdominal obesity: Waist circumference≥90cm(Male), 85cm(Female) B. Patients whose blood pressure ≥130/85mmHg(systolic blood pressure over 130 or, diastolic blood pressure over 85) or patients who are taking blood pressure medication.
C. Fasting Blood Glucose (FPG)≥ 100mg/dl. D. Patients whose triglyceride ≥150 mg/dl or patients who are taking fibrate. E. High-density lipoprotein cholesterol (HDL) < 40 mg/dl (Male), 50 mg/dl(Female)
- Patients who are able to understand the purpose of this trial and to read and write.
- Patients who are able to use U-healthcare Smartphone for this trial.
- Patients who participate voluntarily and sign the informed consent.
Exclusion Criteria:
- Type I diabetes mellitus patients and type II diabetes mellitus patients requiring insulin therapy.
- Patients currently being hospitalized or planning to hospitalize during the study period.
- Patients were diagnosed with myocardial infarction or stroke within 1 year
- End Stage Renal Disease patients requiring renal replacement therapy, Serum creatinine level is greater than 1.5 times the upper limit of normal.
- Females who are pregnant
- Hepatic failure (severe hepatic dysfunction). Liver Function Test (AST or ALT) is greater than 3 times the upper limit of normal.
- Uncontrolled chronic lung disease.
- Patients with known gallstone.
- Patients who have cognitive disorder or psychiatric problems.
- Patients who are taking anti-obesity medications such as Reductil, Xenical, etc., or patients are planning to receive the medications.
- Patients who are taking Synthroid, diabetes medications or psychiatric medications which may affect on body weight.
- Any clinically significant medical condition including neurologic disease, gastrointestinal disease or malignant tumor, etc., which may affect the test results, or any other medical condition which in the opinion of the investigator makes the patients unsuitable for participation in the trial.
- Patients who have participated in other clinical trial (except for the observational study) within 12 weeks prior to screening visit.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Telemonitoring group
|
The Telemonitoring group will be provided the Smartphone, body composition analyzer and pedometer.
They should visit the site once per every 3 months (12 weeks), and measure their body composition during study period.
After measurement of body composition, the subjects should make transmit measured information through Smartphone into a centralized server of Smart Care Center.
At Smart care Center, care manager will provide remote body composition and activity monitoring and individual obesity case management
다른 이름들:
|
다른: Control group
|
The control group will receive a weighting scale and pedometer.
They should perform the same weight measurement (minimum three times a week) like the intervention group during the study, and measured results should be recorded in a diary of self body weight and the number of steps.
In addition, the subjects should visit the site once per every three months (12 weeks).
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
---|---|
Weight Change from Baseline to 24 weeks
기간: 0 and 24 weeks
|
0 and 24 weeks
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Body Mass Index (BMI) changes
기간: 0 and 24 weeks
|
Reduces of body mass index - BMI=Body weight (kg)/Height2(m) |
0 and 24 weeks
|
Proportion of subjects whose body weight decreased more than 10%
기간: 0 and 24 weeks
|
0 and 24 weeks
|
|
Changes in body fat rate
기간: 0 and 24 weeks
|
Reduces in body fat rate
|
0 and 24 weeks
|
Changes in waist circumference
기간: 0 and 24 weeks
|
Reduces waist circumference
|
0 and 24 weeks
|
Changes in lipid profile
기간: 0 and 24 weeks
|
Changes in lipid profile(total cholesterol, HDL cholesterol, LDL cholesterol triglycerides)
|
0 and 24 weeks
|
Changes in blood pressure
기간: 0 and 24 weeks
|
Blood pressure value when hospital visiting
|
0 and 24 weeks
|
Changes in prevalence rate of metabolic syndrome
기간: 0 and 24 weeks
|
0 and 24 weeks
|
|
Changes in the number of metabolic syndrome components
기간: 0 and 24 weeks
|
Reduce the number of metabolic syndrome components
|
0 and 24 weeks
|
Changes in lifestyle
기간: 0 and 24 weeks
|
Changes in lifestyle such as smoking, drinking, dietary and physical activity, etc
|
0 and 24 weeks
|
Patients' satisfaction
기간: 24 weeks
|
applicable to Only Telemonitoring group
|
24 weeks
|
공동 작업자 및 조사자
스폰서
수사관
- 수석 연구원: Bi-Ryong Cho, Seoul National University Hospital
간행물 및 유용한 링크
일반 간행물
- Oh B, Yi GH, Han MK, Kim JS, Lee CH, Cho B, Kang HC. Importance of Active Participation in Obesity Management Through Mobile Health Care Programs: Substudy of a Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018 Jan 3;6(1):e2. doi: 10.2196/mhealth.8719.
- Oh B, Cho B, Han MK, Choi H, Lee MN, Kang HC, Lee CH, Yun H, Kim Y. The Effectiveness of Mobile Phone-Based Care for Weight Control in Metabolic Syndrome Patients: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2015 Aug 20;3(3):e83. doi: 10.2196/mhealth.4222.
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .